The clinical trial for NTX1088 has progressed to include a new combination arm with KEYTRUDA® and expanded to 5 global sites, including 2 Israeli sites JERUSALEM, Dec. 26, 2023 /PRNewswire/ — Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.